ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Sentisure
|
24K |
12M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
24K
|
12M
|
2
|
|
ASX - By Stock
|
RSG |
Re:
$1 dollar club
|
|
Sentisure
|
51 |
19K |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
51
|
19K
|
4
|
|
ASX - By Stock
|
COE |
Re:
Ann: BMG Wells decommissioning complete
|
|
Sentisure
|
3 |
1.2K |
9 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
3
|
1.2K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Sentisure
|
1.0K |
408K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
408K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
Sentisure
|
160 |
81K |
29 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
81K
|
29
|
|
ASX - By Stock
|
ADT |
Re:
Ann: Investor Presentation
|
|
Sentisure
|
22 |
10K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
22
|
10K
|
4
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Moblan drilling delivers thick, high-grade intersections
|
|
Sentisure
|
107 |
51K |
10 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
107
|
51K
|
10
|
|
ASX - By Stock
|
COE |
Re:
Ann: BMG Wells decommissioning update
|
|
Sentisure
|
12 |
4.5K |
2 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
12
|
4.5K
|
2
|
|
ASX - By Stock
|
COE |
Re:
Ann: BMG Wells decommissioning update
|
|
Sentisure
|
12 |
4.5K |
6 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
12
|
4.5K
|
6
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Sentisure
|
140K |
53M |
30 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
140K
|
53M
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Sentisure
|
14K |
6.7M |
9 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
14K
|
6.7M
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Sentisure
|
20 |
6.3K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
20
|
6.3K
|
12
|
|
ASX - By Stock
|
TBN |
Re:
Ann: SS-1H achieved final IP90 commercial flow rates
|
|
Sentisure
|
19 |
6.8K |
5 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
19
|
6.8K
|
5
|
|
ASX - By Stock
|
SYA |
Re:
Ann: New High-Grade Zones Discovered at North American Lithium
|
|
Sentisure
|
101 |
46K |
7 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
101
|
46K
|
7
|
|
ASX - By Stock
|
LOT |
Re:
Uranium news
|
|
Sentisure
|
86 |
41K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
86
|
41K
|
0
|
|
ASX - By Stock
|
MEI |
Re:
Meteoric Resources - Caldeira Review
|
|
Sentisure
|
14 |
5.2K |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
14
|
5.2K
|
5
|
|
ASX - By Stock
|
MEI |
Re:
General discussion (MEI)
|
|
Sentisure
|
4.9K |
1.9M |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
4.9K
|
1.9M
|
7
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Investor Presentation
|
|
Sentisure
|
44 |
12K |
8 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
44
|
12K
|
8
|
|
ASX - By Stock
|
EMP |
Re:
Ann: Results of Judith-1 Well Gas Production Simulation Modelling
|
|
Sentisure
|
24 |
5.7K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
24
|
5.7K
|
0
|
|
ASX - By Stock
|
COE |
Re:
Ann: Q3 FY24 Quarterly Report
|
|
Sentisure
|
10 |
5.2K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
10
|
5.2K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Medium term milestones
|
|
Sentisure
|
89 |
46K |
20 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
89
|
46K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Sentisure
|
144 |
68K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
68K
|
5
|
|
ASX - By Stock
|
COE |
Re:
Ann: Q3 Quarterly report conference call details
|
|
Sentisure
|
2 |
1.2K |
11 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
2
|
1.2K
|
11
|
|
ASX - By Stock
|
IDX |
Re:
Ann: Half Year Results Investor Presentation
|
|
Sentisure
|
12 |
7.9K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
12
|
7.9K
|
0
|
|
ASX - By Stock
|
COE |
Re:
Ann: Market Update
|
|
Sentisure
|
13 |
6K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
13
|
6K
|
5
|
|
ASX - By Stock
|
MEI |
Re:
General discussion (MEI)
|
|
Sentisure
|
4.9K |
1.9M |
12 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
4.9K
|
1.9M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Sentisure
|
14K |
6.7M |
17 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
14K
|
6.7M
|
17
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
56
|
22K
|
2
|
|
ASX - By Stock
|
RIC |
Re:
Ann: Change in substantial holding
|
|
Sentisure
|
2 |
714 |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
2
|
714
|
2
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Appointment of Debt Advisor for Kayelekera Restart
|
|
Sentisure
|
3 |
1.2K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
3
|
1.2K
|
7
|
|
ASX - By Stock
|
MEI |
Re:
General discussion (MEI)
|
|
Sentisure
|
4.9K |
1.9M |
15 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
4.9K
|
1.9M
|
15
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
56
|
22K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Sentisure
|
1.0K |
408K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
408K
|
5
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
22K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
Sentisure
|
78 |
25K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
25K
|
5
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
6 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
56
|
22K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Largest ever single order
|
|
Sentisure
|
94 |
37K |
6 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
94
|
37K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
Sentisure
|
104 |
59K |
17 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
104
|
59K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Sentisure
|
316 |
165K |
25 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
165K
|
25
|
|
ASX - By Stock
|
ATH |
Re:
Finally Moving North
|
|
Sentisure
|
15 |
3.8K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.8K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned
|
|
Sentisure
|
8 |
2.7K |
5 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8
|
2.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Sentisure
|
380 |
129K |
6 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
129K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Sentisure
|
9.8K |
2.9M |
15 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
Sentisure
|
51 |
33K |
19 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
51
|
33K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Entitlement Offer and Placement Investor Presentation
|
|
Sentisure
|
48 |
15K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
48
|
15K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Sentisure
|
210 |
89K |
4 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
89K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Sentisure
|
210 |
89K |
9 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
89K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Sentisure
|
315 |
158K |
9 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
9
|
|